Author:
Lejeune Catherine,Arveux Patrick,Dancourt Vincent,Béjean Sophie,Bonithon-Kopp Claire,Faivre Jean
Abstract
Objectives: Clinical trials have demonstrated that fecal occult blood screening for colorectal cancer can significantly reduce mortality. However, to be deemed a priority from a public health policy perspective, any new program must prove itself to be cost-effective. The objective of this study was to assess the cost-effectiveness of screening for colorectal cancer using a fecal occult blood screening test, the Hemoccult-II, in a cohort of 100,000 asymptomatic individuals 50–74 years of age.Methods: A decision analysis model using a Markov approach simulates the trajectory of the cohort allocated either to screening or no screening over a 20-year period through several health states. Clinical and economic data used in the model came from the Burgundy trial, French population-based studies, and Registry data.Results: Modeling biennial screening versus the absence of screening over a 20-year period resulted in a 17.7 percent mortality reduction and a discounted incremental cost-effectiveness ratio of 3,357 € per life-year gained among individuals 50–74 years of age. Sensitivity analyses performed on epidemiological and economic data showed the strong impact on the results of colonoscopy cost, of compliance to screening, and of specificity of the screening test.Conclusions: Cost-effectiveness estimates and sensitivity analyses suggest that biennial screening for colorectal cancer with fecal occult blood test could be recommended from the age of 50 until 74. Our findings support the attempts to introduce large-scale population screening programs.
Publisher
Cambridge University Press (CUP)
Reference34 articles.
1. Wahrendorf J , Robra BP , Wiebelt H , et al.1993 Effectiveness of colorectal cancer screening: Results from a population-based case-control evaluation in Saarland, Germany.Eur J Cancer Prev.2:221–227.
2. Mandel JS , Church TR , Ederer F , Bond JH .1999 Colorectal cancer mortality: Effectiveness of biennial screening for fecal occult blood.J Natl Cancer Inst.91:434–437.
3. Borie F , Daures JP , Millat B , et al.2001 Follow-up of patients with colorectal cancer resected for cure in the Herault area. A medico-economical study.Gastroenterol Clin Biol.25:881–884.
4. Jouve JL , Remontet L , Dancourt V , et al.2001 Estimation of screening test (Hemoccult®) sensitivity in colorectal cancer mass screening.Br J Cancer.84:1477–1481.
5. Lazovich D , Weiss NS , Stevens NG , et al.1995 A case-control study to evaluate efficacy of screening for faecal occult blood.J Med Screen.2:84–89.
Cited by
33 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献